BOSTON and ROLLE, Switzerland, June 24, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS SA (SOPH), a healthcare technology company and a leader in data-driven medicine, is pleased to announce that its annual ...
On Wednesday, Ocuphire Pharma, Inc. (NASDAQ:OCUP) announced the all-stock acquisition of Opus Genetics, Inc., a clinical-stage gene therapy company for inherited retinal diseases (IRDs). The merger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results